Bryan Daniel Baum - 18 Jul 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Director
Signature
/s/ Robert Cutler, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
18 Jul 2025
Net transactions value
$0
Form type
4
Filing time
21 Jul 2025, 17:56:55 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Baum Bryan Daniel Director C/O SENTI BIOSCIENCES, INC., 2 CORPORATE DR, FIRST FLOOR, SOUTH SAN FRANCISCO /s/ Robert Cutler, attorney-in-fact 21 Jul 2025 0002077411

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +43,900 $0.000000 43,900 18 Jul 2025 Common Stock 43,900 $1.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 18, 2025, subject to the reporting person's continued service through the applicable vesting date.